Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pra Health (PRAH)

Pra Health (PRAH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,831,417
  • Shares Outstanding, K 63,248
  • Annual Sales, $ 2,872 M
  • Annual Income, $ 153,910 K
  • 60-Month Beta 1.13
  • Price/Sales 2.40
  • Price/Cash Flow 18.48
  • Price/Book 7.27

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 1.33
  • Number of Estimates 5
  • High Estimate 1.35
  • Low Estimate 1.31
  • Prior Year 1.21
  • Growth Rate Est. (year over year) +9.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
97.61 +11.86%
on 11/08/19
110.33 -1.03%
on 12/02/19
+11.80 (+12.12%)
since 11/06/19
3-Month
92.13 +18.52%
on 10/02/19
110.33 -1.03%
on 12/02/19
+5.88 (+5.69%)
since 09/06/19
52-Week
82.12 +32.96%
on 01/04/19
115.50 -5.46%
on 02/25/19
+2.85 (+2.68%)
since 12/06/18

Most Recent Stories

More News
Here's Why You Should Retain PRA Health (PRAH) Stock Now

PRA Health (PRAH) is gaining steadily from expansion in international markets, solid 2019 outlook and growing CRO industry. However, escalating direct costs remain a woe.

XRAY : 58.53 (+0.41%)
CNMD : 114.29 (+0.33%)
CAH : 55.04 (+1.46%)
PRAH : 109.01 (+0.93%)
Janssen Leverages Wearable Technology to Reimagine Clinical Trial Design

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the launch of the next evolution of digital clinical trial design with CHIEF-HF, the first-ever completely decentralized, mobile,...

JNJ : 140.91 (+0.97%)
PRAH : 109.01 (+0.93%)
Pra Health Scien Set to Possibly Pullback After Yesterday's Rally of 1.44%

Pra Health Scien (NASDAQ:PRAH) traded in a range yesterday that spanned from a low of $102.07 to a high of $103.72. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high...

PRAH : 109.01 (+0.93%)
PRA Health (PRAH) Q3 Earnings and Revenues Beat Estimates

PRA Health (PRAH) raises 2019 EPS view after a solid third-quarter show.

TMO : 320.54 (+1.44%)
EW : 242.61 (-0.14%)
RMD : 151.22 (+0.69%)
PRAH : 109.01 (+0.93%)
PRA Health Sciences (PRAH) Beats Q3 Earnings and Revenue Estimates

PRA Health Sciences (PRAH) delivered earnings and revenue surprises of 1.54% and 1.01%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

PRAH : 109.01 (+0.93%)
PRA Health Sciences: 3Q Earnings Snapshot

RALEIGH, N.C. (AP) _ PRA Health Sciences Inc. (PRAH) on Wednesday reported third-quarter profit of $83 million.

PRAH : 109.01 (+0.93%)
PRA Health Sciences, Inc. Reports Third Quarter 2019 Results and Updates Full Year 2019 Guidance

-- Net new business of $669.4 million; Net book-to-bill of 1.22

PRAH : 109.01 (+0.93%)
Look for Shares of Pra Health Scien to Potentially Pullback after Yesterday's 2.56% Rise

Pra Health Scien (NASDAQ:PRAH) traded in a range yesterday that spanned from a low of $98.42 to a high of $99.89. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high...

PRAH : 109.01 (+0.93%)
Here's Why You Should Add PRA Health to Your Portfolio Now

PRA Health (PRAH) is gaining steadily from expansion in international markets, solid 2019 outlook and growing CRO industry.

SAUHF : 963.6000 (+0.39%)
PRAH : 109.01 (+0.93%)
MCK : 142.98 (+1.69%)
NNCHY : 39.5900 (-2.92%)
PRA Health Sciences to Report Third Quarter 2019 Earnings

PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its third quarter 2019 results after the market closes on Wednesday, October 30, 2019. The Company will also host a conference call on Thursday, October...

PRAH : 109.01 (+0.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade PRAH with:

Business Summary

PRA Health Sciences, Inc. operates as a global contract research organizations providing outsourced clinical development services to the biotechnology and pharmaceutical industries. It offers therapeutic services in the areas of cardio-metabolic, biosimilars, infectious diseases, immunology, neurology...

See More

Key Turning Points

2nd Resistance Point 111.20
1st Resistance Point 109.60
Last Price 109.01
1st Support Level 106.03
2nd Support Level 104.05

See More

52-Week High 115.50
Last Price 109.01
Fibonacci 61.8% 102.75
Fibonacci 50% 98.81
Fibonacci 38.2% 94.87
52-Week Low 82.12

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar